The fusion oncogene VAV1-MYO1F triggers aberrant T-cell receptor signaling in vivo and drives peripheral T-cell lymphoma in mice.
Eur J Immunol
; 53(3): e2250147, 2023 03.
Article
in En
| MEDLINE
| ID: mdl-36541400
Full text:
1
Database:
MEDLINE
Main subject:
Lymphoma, T-Cell, Peripheral
/
Proto-Oncogene Proteins c-vav
Type of study:
Prognostic_studies
Limits:
Animals
/
Humans
Language:
En
Journal:
Eur J Immunol
Year:
2023
Type:
Article
Affiliation country:
Germany